The drug failed as a treatment for hepatitis and Ebola. With federal funding, scientists trained it on the coronavirus.
from NYT > Business https://ift.tt/35oleik
Subscribe to:
Post Comments (Atom)
The biggest winners from Tesla's sales slump
Tesla's sales in the first quarter of 2025 were down 8.6% from the same time last year. Brandon Bell/Getty Images Tesla sales conti...
-
Caroline Purser/Getty Images The S&P 500 has shed 4% since the beginning of the year as Big Tech stocks decline. However, previou...
-
Omnicom CEO John Wren. Emmanuel Dunand/AFP via Getty Images Ad industry insiders say the Omnicom takeover of Interpublic Group could ki...
-
Krisanapong Detraphiphat/Getty Images; Jenny Change-Rodriguez/BI Illustration Goldman Sachs forecasts muted S&P 500 gains, with a ...
No comments:
Post a Comment